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Abstract
Impact evaluations aim to predict the future, but they are rooted in
particular contexts and to what extent they generalize is an open and
important question. We exploit a new data set of results on a wide variety
of interventions and find more heterogeneity than in other literatures. This
has implications for how evidence is generated and used to inform policy.
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1 Introduction
Recent years have seen extraordinary growth in the use of rigorous impact evalua-
tions in the social sciences, particularly in international development. This expansion
of evidence about what works is welcome. However, if this evidence is to be useful in
informing policy, we must also know to what extent the results from impact evalu-
ations generalize to new contexts. Concerns about external validity have stimulated
lively theoretical debates in economics (Deaton, 2010; Pritchett and Sandefur, 2013).
Further, examples of studies which had low external validity have begun to trickle
in (Bold et al., 2010; Allcott, 2015). There is also growing interest in extrapolat-
ing to different contexts (Dehejia et al., 2015; Gechter, 2015; Bandiera et al., 2015;
Kowalski, 2016), but a motivating question has still not been answered: how much
do results truly vary and what does this imply for research and for policy?
This paper provides this evidence. We use a new data set of 15,024 estimates from
635 papers on 20 types of interventions in international development, gathered in the
course of meta-analysis, and find that the results reported are more heterogeneous
than in other fields, such as medicine.
Impact evaluation results are widely cited in reports generated for policymaking
and are often shared without much information about context, study design or even
standard errors. If they were, and if policymakers updated perfectly based on this
information, the dispersion of studies’ results would not be an issue. However, such
information is not typically provided. For example, the World Development Report,
the World Bank’s flagship annual publication that is widely circulated among policy-
makers, does not typically include confidence intervals or similar information, nor is
there room for a detailed description of each study.1 Nor is this issue limited to devel-
opment; at the present time of writing, the plain language two-pagers the Campbell
Collaboration publishes for policymakers also provide limited contextual information
and no standard errors.2 Details about studies’ implementation and other factors are
frequently sparse not just in policy reports, but also in the research papers them-
selves: of the studies considered in this paper, 1 in 5 did not even make clear the
basic detail of who implemented the program.
In order to systematically analyze heterogeneity in studies results, a comprehen-
1World Development Reports from 2010-2016 were checked for standard error information and
only 8 cases were found out of thousands of cited papers.
2Based on all the reviews posted on their website, last accessed March 16, 2016.
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sive and unbiased sample of studies is needed. We use those studies that were included
in meta-analyses and systematic reviews by a non-profit research institute. That or-
ganization, AidGrade, seeks to systematically understand which interventions work
best where. To date, AidGrade has conducted 20 meta-analyses and systematic re-
views of different development programs.3 Data gathered through meta-analyses are
the ideal data to answer the question of how much we can extrapolate from past
results, and since data on these 20 topics were collected in the same way, coding the
same outcomes and other variables, we can look across different types of programs
to see if there are any more general trends that help to explain impact evaluation
results.
A further contribution of this paper is the development of benchmarks or rules of
thumb that researchers or practitioners can use to gauge the relative external validity
of their own work. We discuss several metrics and show typical values across a range
of interventions. Other disciplines have considered generalizability more, so we draw
on the literature relating to meta-analysis, which has been most well-developed in
medicine, as well as the psychometric literature on generalizability theory (Higgins
and Thompson, 2002; Shavelson and Webb, 2001; Briggs and Wilson, 2007).
We find that results are much more heterogeneous than in other fields. Policy
decisions would seem to be improved by careful research designs that pay attention
to the issue of external validity since, as it stands, the na¨ıve prediction of the effect
of a program might differ from the actual value obtained by close to 100%.
Though this paper focuses on results of impact evaluations in development, as one
of the first fields within economics with enough papers on comparable topics to do this
analysis, external validity is a great concern in many fields. As more rigorous impact
evaluations are completed, opportunities for research relating to external validity will
continue to grow.
2 Theory
We can think of two general models of the world: in the first case, there is one true
effect of a particular program and all differences between studies can be attributed
3Throughout, we will refer to all 20 as meta-analyses, but some did not have enough comparable
outcomes for meta-analysis and became systematic reviews.
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simply to sampling error. In other words:
Yi “ θ ` εi (1)
where θ is the true effect and εi is the error term.
In the second case, the true effect could potentially vary from context to context.
Here,
Yi “ θi ` εi (2)
“ θ¯ ` ηi ` εi (3)
where θ¯ is the mean true effect size, ηi is a particular study’s divergence from that
mean true effect size, and εi is the error.
These two general models correspond to the fixed effect and random-effects mod-
els for meta-analysis, where θi and εi are assumed to both be normally distributed.
We do not need to impose whether a fixed effect or random-effects model better fits
the data; we can simply look to the data and estimate the degree of across-study
variation, τ 2, as well as the sampling variance, σ2. τ 2 “ 0 indicates complete pooling;
as τ 2 Ñ 8, we cannot pool at all.
Random-effects models are necessary if we think there are heterogeneous treat-
ment effects and they will turn out to be more plausible given the data. We can
imagine building from the random effects model to incorporate explanatory vari-
ables, generating mixed models; we will also use mixed models to explain more of the
observed heterogeneity.
It should be noted that meta-analysis also allows us to improve our estimates of
any one given study’s treatment effect. In the random-effects model, the estimated
true treatment effect pθi can be shown to be equal to:
pθi “ Yiσ2i ` µτ21
σ2i
` 1
τ2
(4)
where Yi are the estimates of effect sizes from individual studies, σ
2
i is the sampling
variance, τ 2 is the component of the variation of Yi that is not sampling variance, and
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µ is the grand mean across studies.4 As pθi depends on both Yi and µ, it can perform
better than the original study’s estimate Yi at predicting the effects of a replication,
especially in the presence of large sampling variance (Stein, 1955; Efron and Morris,
1975).
3 Data
This paper uses a database of impact evaluation results collected by AidGrade, a
U.S. non-profit research institute founded by the author in 2012. AidGrade focuses on
gathering the results of impact evaluations and analyzing the data, including through
meta-analysis. Its data on impact evaluation results were collected in the course of
its meta-analyses from 2012-2014 (AidGrade, 2016a).
AidGrade’s meta-analyses follow the standard stages: (1) topic selection; (2) a
search for relevant papers; (3) screening of papers; (4) data extraction; and (5) data
analysis. In addition, it pays attention to (6) dissemination and (7) updating of re-
sults. Here, we will discuss the selection of papers (stages 1-3) and the data extraction
protocol (stage 4); more detail is provided in Appendix E.
3.1 Selection of Papers
The interventions that were selected for meta-analysis were selected largely on the
basis of there being a sufficient number of studies on that topic. Five AidGrade staff
members each independently made a preliminary list of interventions for examination;
the lists were then combined and searches done for each topic to determine if there
were likely to be enough impact evaluations for a meta-analysis. The list remaining
after excluding topics with insufficient studies was voted on by the general public
online and partially randomized. Appendix E provides further detail.
A comprehensive literature search was done using a mix of the search aggregators
SciVerse, Google Scholar, and EBSCO/PubMed. The online databases of the Abdul
Latif Jameel Poverty Action Lab (J-PAL), Innovations for Poverty Action (IPA),
the Center for Effective Global Action (CEGA), and the International Initiative for
Impact Evaluation (3ie) were also searched for completeness. Finally, the references
4Vivalt (2016b) contains a full exposition of both the random-effects and mixed model and
derivation of their estimation strategies.
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of any existing systematic reviews or meta-analyses were collected.
Any impact evaluation which appeared to be on the intervention in question was
included, barring those in developed countries.5 Any paper that tried to consider
the counterfactual of no intervention was considered an impact evaluation. Both
published papers and working papers were included. The search and screening criteria
were deliberately broad. The full text of the search terms and inclusion criteria for
all 20 topics in this paper are available in an online appendix as detailed in Appendix
A.
3.2 Data Extraction
The subset of the data on which we focus is based on those papers that passed all
screening stages in the meta-analyses. Again, the search and screening criteria were
very broad and, after passing the full text screening, the vast majority of papers that
were later excluded were excluded merely because they had no outcome variables in
common or did not provide sufficient data for analysis (for example, not providing
data that could be used to calculate the standard error of an estimate or displaying
results only graphically). The small overlap of outcome variables is a surprising and
notable feature of the data. Ultimately, the data we draw upon for this paper consist
of 15,024 results (double-coded and then reconciled by a third researcher) across 635
papers covering the 20 types of development program listed in Table 1.6 Only 307 of
these papers overlapped in outcomes with another paper on the same intervention.
The small overlap of outcome variables is a surprising and notable feature of the data
and suggests researchers should coordinate more.
When considering the variation of effect sizes within a set of papers, the defini-
tion of the set is clearly critical. Two different rules were used to define outcomes:
a strict rule, under which only identical outcome variables are considered alike (e.g.
height in centimeters), and a loose rule, under which similar but distinct outcomes
are grouped into clusters (e.g. one study may consider a subject to have anemia if
5High-income countries, according to the World Bank’s classification system (2015).
6Three titles here may be misleading. “Mobile phone-based reminders” refers specifically to
SMS or voice reminders for health-related outcomes. “Women’s empowerment programs” required
an educational component to be included in the intervention and it could not be an unrelated inter-
vention that merely disaggregated outcomes by gender. Finally, “micronutrient supplementation”
was initially too loosely defined; this was narrowed down to focus on those providing zinc to children,
but the other micronutrient papers are still included in the greater data set, with a tag, and are
used to examine other issues in other papers, such as publication bias.
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Table 1: List of Development Programs Covered
2012 2013
Conditional cash transfers Contract teachers
Deworming Financial literacy training
Improved stoves HIV education
Insecticide-treated bed nets Irrigation
Microfinance Micro health insurance
Safe water storage Micronutrient supplementation
Scholarships Mobile phone-based reminders
School meals Performance pay
Unconditional cash transfers Rural electrification
Water treatment Women’s empowerment programs
their hemoglobin is less than X; another may consider a subject to have anemia if
their hemoglobin is less than Y). This paper uses the strict rule wherever possible.7
Clearly, even under the strict rule, differences between the studies may exist, how-
ever, using two different rules allows us to isolate the potential sources of variation,
and other variables were coded to capture some of this variation, such as the age of
those in the sample. In total, 73 variables were coded for each paper. Additional
topic-specific variables were coded for some sets of papers, such as the median and
mean loan size for microfinance programs. This paper focuses on the variables held
in common across the different topics. These include which method was used; if ran-
domized, whether it was randomized by cluster; whether it was blinded; where it was
(village, province, country); what kind of institution carried out the implementation;
characteristics of the population; and the duration of the intervention from the base-
line to the midline or endline results, among others. A full set of variables and the
coding manual is available online, as detailed in Appendix A. If one were to divide
the studies by all these characteristics, however, the data would usually be too sparse
for analysis.
Interventions were also defined separately and coders were also asked to write a
short description of the details of each program. Program names were recorded so as
to identify those papers on the same program. For papers which were follow-ups, the
most recent results were used for each outcome.
7Using the loose definition preserves more data for anemia and malaria, so for these outcomes
the loose definition is used.
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Most analyses in this paper use the unstandardized “raw” results data reported in
papers, however, the data were also standardized to be able to provide a set of results
more comparable with the literature and so as not to overweight those outcomes with
larger scales in some analyses. The typical way to compare results across different
outcomes is to use the standardized mean difference, defined as SMD “ µ1´µ2
σp
, where
µ1 is the mean outcome in the treatment group, µ2 is the mean outcome in the control
group, and σp is the pooled standard deviation. The Appendix describes the alterna-
tive procedures used for generating the SMD when these data were not available. The
signs of the results were also adjusted so that a positive effect size always represents
an improvement.
As this paper pays particular attention to the program implementer, it is worth
discussing how this variable was coded in more detail. There were several types
of implementers that could be coded: governments, NGOs, private sector firms, and
academics. There was also a code for “other” or “unclear”. The vast majority of stud-
ies were implemented by academic research teams and NGOs. This paper considers
NGOs and academic research teams together because it turned out to be practically
difficult to distinguish between them in the studies, especially as the passive voice
was frequently used (e.g. “X was done” without noting who did it).
Studies tend to report results for multiple specifications. AidGrade focused on
those results least likely to have been influenced by author choices: those with the
fewest controls, apart from fixed effects. Where a study reported results using dif-
ferent methodologies, coders were instructed to collect the findings obtained under
the authors’ preferred methodology; where the preferred methodology was unclear,
coders were advised to follow the internal preference ordering of prioritizing random-
ized controlled trials, followed by regression discontinuity designs and differences-in-
differences, followed by matching, and to collect multiple sets of results when they
were unclear on which to include. Where results were presented separately for mul-
tiple subgroups, coders were similarly advised to err on the side of caution and to
collect both the aggregate results and results by subgroup except where the author
appeared to be only including a subgroup because results were significant within that
subgroup. For example, if an author reported results for children aged 8-15 and then
also presented results for children aged 12-13, only the aggregate results would be
recorded, but if the author presented results for children aged 8-9, 10-11, 12-13, and
14-15, all subgroups would be coded as well as the aggregate result when presented.
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Authors only rarely reported isolated subgroups, so this was not a major issue in
practice.
A note must be made about combining data. When conducting a meta-analysis,
the Cochrane Handbook for Systematic Reviews of Interventions recommends col-
lapsing the data to one observation per intervention-outcome-paper, and we do this
for generating the within intervention-outcome meta-analyses (Higgins and Green,
2011). Where results had been reported for multiple subgroups (e.g. women and
men), we aggregated them as in the Cochrane Handbook’s Table 7.7.a. Where re-
sults were reported for multiple time periods (e.g. 6 months after the intervention
and 12 months after the intervention), we used the most comparable time periods
across papers.
Finally, one paper appeared to misreport results, suggesting implausibly low val-
ues and standard deviations for hemoglobin. This observation was excluded and the
paper’s corresponding author contacted.
3.3 Data Description
Figure 1 summarizes the distribution of studies across interventions and outcomes.
Attention will typically be limited to those intervention-outcome combinations on
which we have data for at least three papers.
Table 10 in Appendix C lists the interventions and outcomes and describes their
results in a bit more detail, providing the distribution of significant and insignificant
results. It should be emphasized that the number of negative and significant, insignif-
icant, and positive and significant results per intervention-outcome combination only
provide ambiguous evidence of the typical efficacy of a particular type of intervention.
Simply tallying the numbers in each category is known as “vote counting” and can
yield misleading results if, for example, some studies are underpowered.
Table 2 further summarizes the distribution of papers across interventions and
highlights the fact that papers exhibit very little overlap in terms of outcomes stud-
ied. This is consistent with the story of researchers each wanting to publish one
of the first papers on a topic. Vivalt (2015) finds that later papers on the same
intervention-outcome combination more often remain as working papers.
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Figure 1: Number of Papers on Each Unstandardized Outcome by Intervention
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Table 2: Descriptive Statistics: Distribution of Narrow Outcomes
Intervention Number of Mean papers Max papers
outcomes per outcome per outcome
Conditional cash transfers 15 18 36
Contract teachers 1 3 3
Deworming 12 13 17
Financial literacy 3 5 5
HIV/AIDS Education 5 6 10
Improved stoves 4 2 2
Insecticide-treated bed nets 1 18 18
Irrigation 2 2 2
Micro health insurance 4 2 2
Microfinance 6 4 5
Micronutrient supplementation 22 23 37
Mobile phone-based reminders 2 4 5
Performance pay 1 3 3
Rural electrification 3 3 3
Safe water storage 1 2 2
Scholarships 3 2 3
School meals 3 3 3
Unconditional cash transfers 3 10 13
Water treatment 3 8 10
Women’s empowerment programs 2 2 2
Average 4.8 6.6 9.1
4 Measures of Generalizability
There is a rich literature on generalizability theory, originally developed in psy-
chometrics (e.g. Briggs and Wilson, 2007; Higgins and Thompson, 2002; Shavelson
and Webb, 1991), but clearly also applicable to development. As there is currently
no consensus in the economic literature on the best method for estimating general-
izability, this paper reviews several potential measures and discusses the advantages
and disadvantages of each. Acknowledging the diversity of potentially informative
measures, the paper estimates the heterogeneity in each intervention-outcome combi-
nation using several different measures. Specifically, we provide measures of both the
variability of results (the variance and coefficient of variation) and the proportion of
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variation that can be explained (the I2).8
We will also separate out the sampling variance and use explanatory variables
to reduce the unexplained heterogeneity, resulting in the amount of residual varia-
tion in Yi, the coefficient of residual variation, and the residual I
2. Appendix B has
more information on these measures and motivates their use. It is important to note
that each measure captures different things and has advantages and disadvantages, as
summarized in Tables 8 and 9 in that section. For example, the I2, which compares
within and across-study variation, is often preferred by Bayesians, as it relates to
the pooling factor (Rubin, 1981). However, it has been noted it would be artificially
inflated in cases in which a study has a very large sample size and consequently small
standard errors. Again, given the lack of consensus on measures, the reader is referred
to Appendix B for a more complete discussion of the advantages and disadvantages
of various metrics, and results for multiple measures will be presented in the text.
5 Results
5.1 Na¨ıve Approach: Without Modeling Heterogeneity
Figures 2 and 3 summarize the variation in reported results by intervention and
by intervention-outcome combination, respectively. In Figure 3, sparklines show the
most recent point estimate and confidence intervals; when multiple studies were
conducted for a given intervention-outcome in the same year, these were combined
by random-effects meta-analysis. In general, no one intervention is clearly better at
obtaining a particular outcome, and the picture provided by the most recent point
estimate often changes dramatically from year to year. The confidence intervals
frequently overlap, but this would be neglected if policymakers are not provided with
them or do not put much weight on them.
8The I2 is a measure used in the meta-analysis literature and is equal to τ
2
τ2`σ2 . Higgins and
Thompson introduce and motivate its use (2002).
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Figure 2: Dispersion of Estimates
This figure illustrates the range and density of effect sizes found for each intervention. One
observation with an effect size greater than 2 is omitted for legibility.
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Figure 3: Variation by Intervention-Outcome
Intervention Outcome Min Max Units Treatment Effect              
Bed Nets Malaria -0.77 -0.24 log risk ratio
Conditional Cash Transfers Attendance rate 0.02 0.10 percentage points
Conditional Cash Transfers Enrollment rate 0.00 0.16 percentage points
Conditional Cash Transfers Gave birth at healthcare facility 0.00 0.16 percentage points
Conditional Cash Transfers Height-for-age -0.22 0.09 standard deviations
Conditional Cash Transfers Labor force participation -0.10 0.07 percentage points
Conditional Cash Transfers Labor hours -5.56 0.29 hours/week
Conditional Cash Transfers Pregnancy rate -0.08 0.01 percentage points
Conditional Cash Transfers Probability unpaid work -0.19 0.07 percentage points
Conditional Cash Transfers Retention rate -0.04 0.00 percentage points
Conditional Cash Transfers Skilled attendant at delivery 0.04 0.19 percentage points
Conditional Cash Transfers Test scores -0.06 0.15 standard deviations
Conditional Cash Transfers Unpaid labor hours -3.94 -0.41 hours/week
Contract Teachers Test scores 0.14 0.27 standard deviations
Deworming Height -0.64 0.84 cm
Deworming Height-for-age -0.04 0.37 standard deviations
Deworming Hemoglobin -0.08 0.22 g/dL
Deworming Mid-upper arm circumference -0.05 0.50 cm
Deworming Weight -0.28 1.30 kg
Deworming Weight-for-age -0.05 0.37 standard deviations
Deworming Weight-for-height -0.14 0.47 standard deviations
Financial Literacy Has savings 0.01 0.04 percentage points
Financial Literacy Has taken loan -0.01 0.04 percentage points
Financial Literacy Savings 10.95 23.59 current US$
HIV/AIDS Education Used contraceptives -0.07 0.13 percentage points
Microfinance Assets -112.59 178.61 current US$
Microfinance Profits -119.20 96.20 current US$
Microfinance Savings -1.17 125.09 current US$
Microfinance Total income -1.49 50.17 current US$
Intervention Outcome Min Max Units Treatment Effect              
Micronutrients Birthweight 0.01 0.10 kg
Micronutrients Body mass index -0.03 0.35 kg/m^2
Micronutrients Diarrhea incidence -0.26 0.02 log risk ratio
Micronutrients Diarrhea prevalence -1.04 -0.05 log risk ratio
Micronutrients Height -0.50 1.50 cm
Micronutrients Height-for-age -0.04 0.38 standard deviations
Micronutrients Hemoglobin -0.36 0.68 g/dL
Micronutrients Mid-upper arm circumference -0.06 0.10 cm
Micronutrients Mortality -1.11 0.29 log risk ratio
Micronutrients Perinatal death -0.19 0.30 log risk ratio
Micronutrients Prevalence of anemia -0.90 0.00 log risk ratiolog risk ratio
Micronutrients Stillbirth -0.24 0.80 log risk ratio
Micronutrients Stunted -0.25 0.06 log risk ratio
Micronutrients Test scores -0.10 0.23 standard deviations
Micronutrients Weight -0.10 0.50 kg
Micronutrients Weight-for-age -0.01 0.36 standard deviations
Micronutrients Weight-for-height -0.07 0.20 standard deviations
Performance Pay Test scores 0.05 0.15 standard deviations
Rural Electrification Enrollment rate 0.07 0.09 percentage points
Rural Electrification Study time -0.21 2.06 hours/day
SMS Reminders Appointment attendance rate 0.11 0.21 log risk ratio
Scholarships Enrollment rate 0.01 0.21 percentage points
School Meals Enrollment rate 0.02 0.26 percentage points
School Meals Test scores 0.02 0.29 standard deviations
Unconditional Cash Transfers Enrollment rate 0.01 0.19 percentage points
Water Treatment Diarrhea incidence -0.92 -0.27 log rate ratio
Water Treatment Diarrhea prevalence -0.77 0.02 log rate ratio
Water Treatment Dysentery incidence -1.61 -0.45 log rate ratio
Each row’s black line graphically depicts the most recent estimate of Yi for that intervention-outcome combination; the grey shaded areas, the confidence intervals.
Where multiple such results are reported for a year, they are combined using random-effects meta-analysis. In years with no new data, the line is flat. The sparklines
reflect what someone who took the most recent estimate as the “true” effect of the intervention would think the effect was each year. The data run horizontally from
1982 to 2014, and each row is scaled vertically for legibility with the minimum and maximum point on the black line provided. Since data are collapsed by year, this
figure understates the heterogeneity. Unstandardized data are used.
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Table 3: Heterogeneity Measures
|Yi ´ pYi|{|Yi| CV(Yi) I2
20th percentile 0.40 0.73 0.01
40th percentile 0.74 1.09 0.70
60th percentile 1.39 1.84 0.97
80th percentile 3.22 2.46 1.00*
Percentiles for each measure are calculated separately; the intervention-outcome combination at
the 20th percentile for I2, for example, need not be the intervention-outcome combination at the
20th percentile for the coefficient of variation of Yi. The prediction error |Yi ´ pYi|{|Yi| is calculated
by study, where pYi is the mean value of Yi within that intervention-outcome combination prior to
the study. The other measures are calculated by intervention-outcome combination. These are
broken down by intervention-outcome in the Appendix (Table 11). The I2 is rounded to 1 where
designated with an asterisk.
Table 3 presents several key statistics. The first column provides the absolute
value of the prediction error in percent terms, |Yi ´ pYi|{|Yi|, where pYi is the sim-
plest, na¨ıve predictor of a study’s result, Yi: the mean Yi for all studies previously
completed within that intervention-outcome. The median amount by which the pre-
diction differs from the true value is 93% using unstandardized values of Yi or 99%
using standardized values.9 In standardized values, the average absolute value of the
error is 0.18, compared to an average effect size of 0.12.
If instead of using the mean result in prior time periods as pYi we were to use the
inverse-variance weighted meta-analysis result in prior time periods as pYi, the median
absolute percent difference between pYi and Yi would be 89% using standardized data
and 88% using unstandardized data, and if we were to use the median result in prior
time periods, it would be 92% and 88%, respectively. These values are fairly large
and there is not much difference between the results using standardized and unstan-
dardized values.
The next set of statistics reported in Table 3 are the coefficient of variation and
I2, as estimated by hiearchical Bayesian meta-analysis. These use unstandardized
values of Yi. How should we interpret these numbers? Higgins and Thompson, who
defined I2, suggested 0.25 indicative of low, 0.5 moderate, and 0.75 high levels of
heterogeneity (2002). The studies show a lot of systematic variation according to this
scale. No defined benchmarks exist for the coefficient of variation, but studies in the
9This is the median of |Yi ´ pYi|{|Yi|, omitting the 25 observations with Yi “ 0.
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Figure 4: Distribution of Within and Across-Paper Variance
This figure plots the standardized variance of results within a paper against the variance of results
across papers within an intervention-outcome combination. As there are a few outliers in the right
tail, the 14 observations with variances above 0.25 are dropped for this figure.
medical literature often exhibit a coefficient of variation of approximately 0.05-0.5
(Ng, 2014; Tian, 2005). By this standard, too, results would appear quite heteroge-
neous. Results are broken down by intervention-outcome in Table 11.
An alternative benchmark that might have intuitive appeal is that of the average
within-study variation within an intervention-outcome. If the across-study variation
approached the within-study variation, we might not be so concerned about external
validity across different contexts, though it should be noted that there is no guar-
antee within-study variation would be bounded by across-study variation. A paper
might report multiple results for an intervention-outcome combination if, for exam-
ple, it were reporting results for different subgroups, such as for different age groups,
genders, or geographic areas. Figure 4 shows the distribution of the within-paper
variance compared to the distribution of the across-paper variance. Not all studies
report multiple results for an intervention-outcome combination. Within-study vari-
ation appears lower than across-study variation, but not by much. Table 12 provides
additional details and compares the within-paper and across-paper coefficient of vari-
ation and I2 measures by intervention-outcome.
Finally, we can try to derive benchmarks more directly, based on the expected
prediction error. What counts as large or small error depends on the policy question.
In some cases, it might not matter if a treatment effect were mispredicted by 25%.
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In others, a prediction error of this magnitude could mean the difference between
choosing one program over another or whether a program is worthwhile to pursue at
all.
Still, if we take the mean treatment effect within an intervention-outcome to be
our best guess of how a program will perform and, as an illustrative example, want
the prediction error to be less than 25% at least 50% of the time, this would imply
a certain cut-off threshold for the variance, assuming that results are normally dis-
tributed and the mean and variance of this distribution can be approximated by the
mean and variance of the observed results.
Table 13 provides the implied bounds for var(Yi) for the prediction error to be less
than 25% or 50%, respectively, at least 50% of the time, alongside the actual variance
in results within each intervention-outcome. In only 2 of 57 intervention-outcome
combinations is the true variance in results smaller than the variance implied by the
25% prediction error cut-off threshold, and in 14 other cases it is below the 50% pre-
diction error threshold. In other words, for more than 70% of intervention-outcomes,
the implied prediction error is greater than 50% more than 50% of the time.
While this is merely a back-of-the-envelope calculation, it highlights that in order
to inform policy, modeling heterogeneity of treatment effects is of first-order impor-
tance.
5.1.1 Robustness Checks
One may be concerned that low-quality papers are either inflating or depressing
the degree of heterogeneity that is observed. There are many ways to measure paper
quality; two are considered here.10
First, we use the most widely-used quality assessment measure, the Jadad scale
(Jadad et al., 1996). The Jadad scale asks whether the study was randomized, double-
blind, and whether there was a description of withdrawals and dropouts. A paper
gets one point for having each of these characteristics; in addition, a point is added if
the method of randomization was appropriate, subtracted if the method is inappro-
priate, and similarly added if the blinding method was appropriate and subtracted if
inappropriate. This results in a 0-5 point scale. Given that the kinds of interventions
10Additional robustness checks can be provided on request. We acknowledge that there are
many ways to measure paper quality but would argue that what is most relevant is the information
provided to policymakers, and they often do not know which methods a study used, let alone receive
assessments of a paper’s quality.
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being tested are not typically suited to blinding, we consider all those papers scoring
at least a 3 to be high quality.
In an alternative specification, we also consider only those results from studies
that were RCTs. This is for two reasons. First, RCTs are the gold standard in im-
pact evaluation. Second, a separate paper finds that RCTs exhibit the fewest signs
of specification searching and publication bias (Vivalt, 2015). Looking at only those
studies which were RCTs thus provides a good robustness check.
Tables 14-15 provide results using the data that meet these two quality criteria.
The heterogeneity measures are not substantially different using these data.
5.2 Modeling Heterogeneity
5.2.1 Across Intervention-Outcomes
If the heterogeneity in outcomes that has been observed can be systematically
modeled, we might be able to make better predictions. We first look across differ-
ent intervention-outcome combinations to examine whether effect sizes are associated
with any characteristics of the study or sample, before turning to look within an
intervention-outcome combination. To look across intervention-outcome combina-
tions, we use standardized values.
Table 4 presents results. First, there is some evidence that studies with a smaller
number of observations have greater effect sizes than studies based on a larger number
of observations. This is what we would expect if specification searching were easier in
small data sets; this pattern of results would also be what we would expect if power
calculations drove researchers to only proceed with studies with small sample sizes if
they believed the program would result in a large effect size or if larger studies are
less well-targeted. Interestingly, government-implemented programs have lower effect
sizes even controlling for sample size.11 Studies in the Middle East / North Africa
region may appear to perform slightly better than those in Sub-Saharan Africa (the
excluded region category), but not much weight should be put on this as very few
studies were conducted in the former region. RCTs do not exhibit significantly dif-
ferent results than quasi-experimental studies.
While looking across intervention-outcomes has the advantage of letting us draw
on a larger sample of studies, and we might think that any patterns observed across so
11The dummy variable category left out is private sector-implemented interventions.
18
many interventions and outcomes would be fairly robust, we might be able to explain
more variation if we restrict attention to within a particular intervention-outcome
combination. We therefore focus on the case of conditional cash transfers (CCTs)
and enrollment rates, as this is the intervention-outcome combination that contains
the largest number of papers that should be familiar to economists.12
Table 4: Regression of Effect Size on Study Characteristics
(1) (2) (3) (4) (5)
Number of -0.013** -0.013** -0.011**
observations (100,000s) (0.01) (0.01) (0.00)
Government-implemented -0.081*** -0.073***
(0.02) (0.03)
Academic/NGO-implemented -0.018 -0.020
(0.01) (0.01)
RCT 0.021
(0.02)
East Asia 0.002
(0.03)
Latin America -0.003
(0.03)
Middle East/North 0.193**
Africa (0.08)
South Asia 0.021
(0.04)
Constant 0.112*** 0.144*** 0.093*** 0.103*** 0.146***
(0.00) (0.01) (0.02) (0.02) (0.01)
Observations 528 597 611 528 521
R2 0.19 0.22 0.21 0.21 0.19
Each column reports the results of regressing the standardized effect size on different explanatory
variables, dropping one outlier with an effect size greater than 2. Standard errors are clustered by
intervention-outcome. Different columns contain different numbers of observations because not all
studies reported each explanatory variable. Projects implemented by the private sector comprise
the excluded implementer group, and the excluded region is Sub-Saharan Africa.
12There are more studies on micronutrients, but this is a less traditional topic for economists.
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5.2.2 Within an Intervention-Outcome: The Case of CCTs and Enroll-
ment Rates
Suppose we were to try to explain as much variation in effects of CCT programs
on enrollment rates as possible using sample characteristics. The available variables
which might plausibly have a relationship to effect size are: the baseline enrollment
rates13; the sample size; whether the study was done in a rural or urban setting, or
both; results for other programs in the same region14; and the age and gender of the
sample under consideration.
Table 5 shows the results of OLS regressions of the effect size on these variables.
The baseline enrollment rates show the strongest relationship to effect size, as reflected
in the R2 and significance levels: it is easier to have large gains where initial rates are
low. Some papers pay particular attention to those children that were not enrolled
at baseline or that were enrolled at baseline. These are coded as a “0%” or “100%”
enrollment rate at baseline but are also represented by two dummy variables (Column
2). Studies done in urban areas also tend to find smaller effect sizes than studies done
in rural or mixed urban/rural areas. There is no significant difference between girls
and boys or based on the age of the sample.15 Finally, for each result we calculate
the mean result in the same region, excluding results from the program in question.
Results do appear slightly correlated across different programs in the same region.
As baseline enrollment rates have the strongest relationship to effect size, we use
this as an explanatory variable in a hierarchical mixed model (specification of Column
1), to explore how it affects the residual variance, coefficient of variation, and I2. We
also use the specification in Column 10 of Table 5 as a robustness check. The results
are reported in Table 6 for each of these two mixed models, alongside the values from
the random-effects model that does not use any explanatory variables.
Not all papers provide information for each explanatory variable, and each row is
based on only those studies which could be used to estimate the model. Thus, the
13In some cases, only endline enrollment rates are reported. This variable is therefore constructed
by using baseline rates for both the treatment and control group where they are available, followed
by, in turn, the baseline rate for the control group; the baseline rate for the treatment group; the
endline rate for the control group; the endline rate for the treatment and control group; and the
endline rate for the treatment group
14Regions include: Latin America, Africa, the Middle East and North Africa, East Asia, and
South Asia, following the World Bank’s geographical divisions.
15Shown here: minimum sample age. Results for other age variables available upon request.
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Table 5: Regression of Projects’ Results on Characteristics (CCTs on Enrollment Rates)
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10)
Enrollment Rates -0.205*** -0.102*** -0.090***
(0.05) (0.03) (0.03)
Enrolled at Baseline 0.001
(0.02)
Not Enrolled at 0.195*** 0.199***
Baseline (0.03) (0.03)
Number of -0.008
Observations (100,000s) (0.01)
Rural 0.038*** 0.013
(0.01) (0.01)
Urban -0.049*** -0.018
(0.01) (0.02)
Girls 0.001
(0.02)
Boys -0.020
(0.01)
Minimum Sample Age 0.001
(0.00)
Mean Regional Result 1.000*
(0.49)
Constant 0.212*** 0.130*** 0.074*** 0.042*** 0.071*** 0.066*** 0.074*** 0.056*** 0.000 0.115***
(0.04) (0.02) (0.02) (0.01) (0.01) (0.02) (0.02) (0.02) (0.03) (0.02)
Observations 249 249 145 270 270 270 270 244 270 249
R2 0.32 0.44 0.00 0.05 0.03 0.00 0.01 0.00 0.02 0.45
Each column regresses the results of evaluations of conditional cash transfer programs on different explanatory variables. Multiple results
for different subgroups may be reported for the same paper; the data on which this table is based includes multiple results from the same
paper for different subgroups that are non-overlapping (e.g. boys and girls, groups with different age ranges, or different geographical areas).
Standard errors are clustered by paper. Not every paper reports every explanatory variable, so different columns are based on different
numbers of observations.
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Table 6: Impact of Mixed Models on Measures
var(Yi) varRpYiq CV(Yi) CVRpYiq I2 I2R N
Random effects 0.007 0.007 1.26 1.26 0.95 0.95 259
Mixed model 1 0.007 0.005 1.29 1.08 0.95 0.90 238
Mixed model 2 0.012 0.006 1.53 1.10 0.97 0.90 125
This table illustrates the impact of mixed models on heterogeneity measures. Mixed model 1 and 2
are specified by Columns 1 and 10 in Table 6. In each row, the random-effects model is used to
form var(Yi), CV(Yi) and I
2; these are regenerated in each row since not all papers report the
covariates used in the mixed models, so each row is based on a slightly different sample. One can
see the measures of residual variation (varRpYiq, CVRpYiq and I2R) are slightly smaller than their
random-effects counterparts, although not enough to approach the medical literature.
value of varpYiq, CV(Yi) and I2, which do not depend on the model used, may still
vary between rows.
In the random-effects model, since no explanatory variables are used, pYi is the
mean, and the measures of residual heterogeneity, varRpYiq, CVRpYiq and I2R, do not
offer improvements on var(Yi), CV(Yi) and I
2. As more explanatory variables are
added, the gap between these measures grows. varRpYiq and CVRpYiq are greatly
reduced from var(Yi) and CV(Yi), but I
2
R is not much lower than I
2. This is likely
due to a feature of I2 (I2R) previously discussed: that it depends on the precision of
estimates. With evaluations of CCT programs tending to have large sample sizes, the
value of I2 (I2R) is higher than it otherwise would be.
This case study restricted attention to the effects of CCTs on enrollment rates. We
might wonder how much better external validity would be for the other intervention-
outcome combinations if we did a similar exercise for each.
It would be difficult to find great explanatory variables for each intervention-
outcome combination, but we can simulate them under different assumptions. We
generate the explanatory variable Xi for each result in the full data set so that re-
gressing Y on X yields a particular R2 within each intervention-outcome combination.
Table 7 shows the results for various R2. Based on the case of CCTs, the results for
R2=0.5 represent the preferred specification.
The main takeaway from this table is that if we had good explanatory vari-
ables, the situation would be greatly improved. We cannot compare Table 7 to the
benchmarks in the medical literature, since these benchmarks were developed without
modeling heterogeneity and we can imagine that the observed variation in that litera-
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Table 7: Residual Heterogeneity Measures
CVR(Yi) I
2
R
R2 “ 0.25
20th percentile 0.59 0.77
40th percentile 0.87 0.86
60th percentile 1.52 0.94
80th percentile 1.98 0.97
R2 “ 0.50
20th percentile 0.51 0.70
40th percentile 0.71 0.82
60th percentile 1.18 0.92
80th percentile 1.61 0.95
R2 “ 0.75
20th percentile 0.31 0.46
40th percentile 0.45 0.74
60th percentile 0.77 0.85
80th percentile 1.06 0.92
This table presents simulation results of what heterogeneity measures might look like for the entire
data set if we had suitable explanatory variables to insert into a mixed model. The residual
coefficient of variation, for example, is calculated using Yi ´ pYi rather than Yi, where pYi is the
fitted value from the mixed model. Thus, the heterogeneity measures are capturing the residual
variation that cannot be explained by the model. The mixed model is simulated by generating an
explanatory variable, Xi, by taking Yi and adding noise. The noise is normally distributed with
mean 0 and a standard deviation equal to 2, 1, or 0.5 times the standard deviation of Yi for each
intervention-outcome. Each result is drawn 100 times. Percentiles for each measure are, as before,
calculated separately.
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ture would likewise decrease if explanatory variables were included. However, we can
compare the variance to the calculated bounds for the prediction error to be less than
25% or 50%. In the preferred specification, 6 intervention-outcome combinations now
have a residual variance less than the 25% prediction error cut-off threshold and 26
have one less than the 50% prediction error threshold.
6 Discussion
Why should we care about the dispersion of studies’ results? If we had perfect
information about the context, intervention, implementation, study quality and con-
fidence intervals, and if we could perfectly model effect sizes and update based on
that information, surely the dispersion would not matter. But that is a high bar,
and it is especially unlikely a policymaker could take these factors into consideration
when the reports they receive do not include this information.16
Reviewing World Development Reports and Campbell Collaboration “plain lan-
guage” reports geared towards policymakers, the most common way of presenting
information is to discursively list the point estimates of studies, sometimes noting
if they are statistically significant.17 It is up to the policymakers to determine how
to weight the different studies to come up with an estimate of how they believe
the program would perform in a particular setting. We must aggregate information
from competing sources all the time, even in the absence of a meta-analysis or other
thoughtful review.18
In light of this, this paper suggests that given the observed variation in studies’ re-
sults, how policymakers combine information from different studies is a fruitful area
for further research. Vivalt (2016a), for example, finds some evidence that people
exhibit “variance neglect” in the same way they often suffer from extension neglect
(sample size neglect): they do not fully take confidence intervals into consideration
when updating. In this case, the point estimates form the basis of updating (approx-
imated in this paper by using the mean point estimate to date as a predictor of the
16Political economy issues may also affect policymakers’ decisions, but we focus on the idealized
case of a policymaker who wants to make evidence-based decisions.
17Even then, they may not note at which level of significance. Results are also sometimes provided
more qualitatively, e.g. “Group A showed higher levels of X than Group B”, without reporting
magnitudes.
18Thanks to Elizabeth Tipton for making this point in personal communication in 2014.
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effect of the next study). There are other risks in how policymakers might view the
headline results reported in policy briefs or academic papers. Without considering
confidence intervals, policymakers may get the false impression that different inter-
ventions typically have different effects on particular outcomes, whereas if one were
to select a random-effects meta-analysis result based on all data for an intervention-
outcome and compare that to the meta-analysis result for a different intervention on
the same outcome, the confidence intervals would overlap 94% of the time. If pol-
icymakers also pay more attention to the more positive results, this would lead to
those interventions with a greater dispersion of results being considered to have better
effects. This paper underscores the importance of further research to determine how
to best present information to policymakers to enable optimal decision-making.
It is possible that variation in the precise nature of different programs classified
as the “same” intervention for the purpose of analysis explains some of the observed
variation in results. The reports provided to policymakers do not typically include
detailed information on each intervention, so this unexplained variation is a realistic
feature of the information a policymaker would receive. The confidence intervals of
studies’ results are also important, but again it is unlikely policymakers would per-
fectly update based on them if they are not even provided with them.
One might also be concerned that this paper primarily uses standardized values.
As discussed, standardized values can be misleading if the standard deviation of the
outcome variable differs across papers. We saw that the difference appears slight in
practice, and using standardized values buys us the ability to make some additional
statements looking across intervention-outcome combinations, such as in looking at
the variance of Yi and running the regression in Table 4. However, this paper’s main
results do not rely on using standardized values, and any result can be presented
using unstandardized values upon request.
7 Conclusion
How much impact evaluation results generalize to other settings is an important
question. Before now, we did not have data on many different types of interventions,
all collected in the same way, with which to present a broad overview. The issues
underlying external validity are well-known and assessments of external validity will
always remain best conducted on a case-by-case basis. However, with the broad array
25
of results presented here, we can begin to speak a bit more generally about how re-
sults tend to vary across contexts and what that implies for impact evaluation design
and policy recommendations.
We consider several ways to evaluate the magnitude of the variation in results.
Whether results are too heterogeneous ultimately depends on the purpose for which
they are being used; some policy decisions might have greater room for error than
others. However, it is safe to say that these impact evaluations exhibit more hetero-
geneity than is typical in other fields, such as medicine.
We also found evidence of systematic variation in effect sizes that is surprisingly
robust across different interventions and outcomes. Smaller studies tended to have
larger effect sizes, which we might expect if the smaller studies are better-targeted,
are selected to be evaluated when there is a higher a priori expectation they will
have a large effect size, or if there is a preference to report larger effect sizes, which
smaller studies would obtain more often by chance. Government-implemented pro-
grams also had smaller effect sizes than academic/NGO-implemented programs, even
after controlling for sample size. This is unfortunate given we often do smaller im-
pact evaluations with NGOs in the hopes of finding a strong positive effect that can
scale through government implementation and points to the importance of research
on scaling up interventions. RCTs do not appear to have less external validity than
quasi-experimental studies.
We then turn from looking across intervention-outcome combinations to explaining
heterogeneity within a particular intervention-outcome combination and simulating
how results using the broader data set would change if we had good explanatory vari-
ables. We find great improvement in the heterogeneity measures, underscoring that
careful modeling could help substantially.
The results speak to the importance of further research on how policymakers make
decisions given the information they are provided. With more research, we could find
out how to improve the decisions they make.
There are also some steps that researchers can take that may improve the gen-
eralizability of their own studies. First, just as with heterogeneous selection into
treatment (Chassang, Padro´ i Miquel and Snowberg, 2012), one solution would be
to ensure one’s impact evaluation varied some of the contextual variables that we
might think underlie the heterogeneous treatment effects. Given that many studies
are underpowered as it is, that may not be likely; however, large organizations and
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governments have been supporting more impact evaluations, providing more oppor-
tunities to explicitly integrate these analyses. Efforts to coordinate across different
studies, asking the same questions or looking at some of the same outcome variables,
would also help. The framing of heterogeneous treatment effects could also provide
positive motivation for replication projects in different contexts: different findings
would not necessarily negate the earlier ones but add another level of information.
In summary, generalizability is not binary but something that we can measure.
Policymakers should take caution when extrapolating from studies done in other con-
texts, and researchers should pay more attention to sampling variance, modeling,
coordination, and replication.
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Appendices
A Guide to Appendices
A.1 Appendices in this Paper
B) Discussion of heterogeneity measures.
C) Additional results.
A.2 Further Online Appendices
Having to describe data from twenty different meta-analyses and systematic re-
views, we must rely in part on online appendices. The following are available at
http://www.evavivalt.com/appendices-generalize:
D) Excerpt from AidGrade’s Process Description (2016b).
E) The search terms and inclusion criteria for each topic.
F) Bibliography of included and excluded papers.
G) The coding manual.
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B Heterogeneity Measures
As discussed in the main text, we will want measures that speak to both the
overall variability as well as the amount that can be explained.
The most obvious measure to consider is the variance of studies’ results, var(Yi).
A potential drawback to using the variance as a measure of generalizability is that
we might be concerned that studies that have higher effect sizes or are measured
in terms of units with larger scales have larger variances. This would limit us to
making comparisons only between data with the same scale. We could either: 1)
restrict attention to those outcomes in the same natural units (e.g. enrollment rates
in percentage points); 2) convert results to be in terms of a common unit, such as
standard deviations19; or 3) scale the measure, such as by the mean result, to create
a unitless figure. Scaling the standard deviation of results within an intervention-
outcome combination by the mean result within that intervention-outcome creates
a measure known as the coefficient of variation, which represents the inverse of the
signal-to-noise ratio, and as a unitless figure can be compared across intervention-
outcome combinations with different natural units. It is not immune to criticism,
however, particularly in that it may result in large values as the mean approaches
zero.
The measures discussed so far focus on variation. However, if we could explain the
variation, it would no longer worsen our ability to make predictions in a new setting,
so long as we had all the necessary data from that setting, such as covariates, with
which to extrapolate. One portion of the variation that can be immediately explained
is the sampling variance, varpYi|θiq, denoted σ2. The variation in observed effect sizes
is:
varpYiq “ τ 2 ` σ2 (5)
and the proportion of the variation that is not sampling error is:
I2 “ τ
2
τ 2 ` σ2 (6)
The I2 is an established metric in the meta-analysis literature that helps deter-
mine whether a fixed or random-effects model is more appropriate; the higher I2, the
19This can be problematic if the standard deviations themselves vary but is a common approach
in the meta-analysis literature in lieu of a better option.
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Table 8: Summary of Heterogeneity Measures
Measure of variation Measure of propor-
tion of variation that
is systematic
Measure makes use
of explanatory vari-
ables
varpYiq X
varRpYiq X X
CVpYiq X
CVRpYiq X X
I2 X
I2R X X
R2 X X
less plausible it is that sampling error drives all the variation in results, and the more
appropriate a random-effects model is. I2 is considered “low” at 0.25, “moderate” at
0.5, and “high” at 0.75 (Higgins et al., 2003).20
If we wanted to explain more of the variation, we could use a mixed model and,
upon estimating it, we can calculate several additional statistics: the amount of
residual variation in Yi, after accounting for Xn, varRpYiq, the coefficient of residual
variation, CVRpYiq, and the residual I2R. Further, we can examine the R2 of the meta-
regression.
It should be noted that a linear meta-regression is only one way of modeling vari-
ation in Yi. The I
2, for example, is analogous to the reliability coefficient of classical
test theory or the generalizability coefficient of generalizability theory (a branch of
psychometrics), both of which estimate the proportion of variation that is not er-
ror. In this literature, additional heterogeneity is usually modeled using ANOVA
rather than meta-regression. Modeling variation in treatment effects also does not
have to occur only retrospectively at the conclusion of studies; we can imagine that a
carefully-designed study could anticipate and estimate some of the potential sources
of variation experimentally.
Table 8 summarizes the different indicators, dividing them into measures of vari-
ation and measures of the proportion of variation that is systematic.
Each of these metrics has its advantages and disadvantages. Table 9 summarizes
the desirable properties of a measure of heterogeneity and which properties are pos-
20The Cochrane Collaboration uses a slightly different set of norms, saying 0-0.4 “might not
be important”, 0.3-0.6 “may represent moderate heterogeneity”, 0.5-0.9 “may represent substantial
heterogeneity”, and 0.75-1 “considerable heterogeneity” (Higgins and Green, 2011).
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Table 9: Desirable properties of a measure of heterogeneity
Does not de-
pend on the
number of
studies in a
cell
Does not de-
pend on the
precision of
individual
estimates
Does not de-
pend on the es-
timates’ units
Does not de-
pend on the
mean result in
the cell
varpYiq X X X
varRpYiq X X X
CVpYiq X X X
CVRpYiq X X X
I2 X X X
I2R X X X
R2 X X X X
A “cell” here refers to an intervention-outcome combination. The “precision” of an estimate refers
to its standard error.
sessed by each of the discussed indicators. Measuring heterogeneity using the variance
of Yi requires the Yi to have comparable units. Using the coefficient of variation re-
quires the assumption that the mean effect size is an appropriate measure with which
to scale sd(Yi). The variance and coefficient of variation also do not have anything to
say about the amount of heterogeneity that can be explained. Adding explanatory
variables also has its limitations. In any model, we have no way to guarantee that
we are indeed capturing all the relevant factors. While I2 has the nice property that
it disaggregates sampling variance as a source of variation, estimating it depends on
the weights applied to each study’s results and thus, in turn, on the sample sizes of
the studies. The R2 has its own well-known caveats, such as that it can be artificially
inflated by over-fitting.
To get a full picture of the extent to which results might generalize, then, multiple
measures should be used.
C Additional Results
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Table 10: Descriptive Statistics: Narrowly Defined Outcomes
Intervention Outcome # Neg sig papers # Insig papers # Pos sig papers # Papers
Conditional cash transfers Attendance rate 0 6 9 15
Conditional cash transfers Enrollment rate 0 7 29 36
Conditional cash transfers Gave birth at healthcare facility 0 2 1 3
Conditional cash transfers Height 0 1 1 2
Conditional cash transfers Height-for-age 0 6 1 7
Conditional cash transfers Labor force participation 1 12 5 18
Conditional cash transfers Labor hours 0 3 4 7
Conditional cash transfers Pregnancy rate 1 1 1 3
Conditional cash transfers Probability unpaid work 1 0 4 5
Conditional cash transfers Retention rate 0 3 2 5
Conditional cash transfers Skilled attendant at delivery 0 3 0 3
Conditional cash transfers Test scores 1 2 2 5
Conditional cash transfers Unpaid labor hours 3 2 0 5
Conditional cash transfers Weight-for-age 0 2 0 2
Conditional cash transfers Weight-for-height 0 1 1 2
HIV/AIDS Education Contracted STD 0 2 1 3
HIV/AIDS Education Has multiple sex partners 0 2 2 4
HIV/AIDS Education Pregnancy rate 0 1 3 4
HIV/AIDS Education Probability sexually active 0 2 1 3
HIV/AIDS Education Used contraceptives 0 2 8 10
Unconditional cash transfers Enrollment rate 0 5 8 13
Unconditional cash transfers Test scores 0 1 1 2
Unconditional cash transfers Weight-for-height 0 2 0 2
Insecticide-treated bed nets Malaria 0 4 14 18
Contract teachers Test scores 0 1 2 3
Deworming Attendance rate 0 1 1 2
Deworming Birthweight 0 2 0 2
Deworming Diarrhea incidence 0 1 1 2
Deworming Height 3 10 3 16
Deworming Height-for-age 1 9 4 14
Deworming Hemoglobin 0 13 1 14
Deworming Malformations 0 2 0 2
Deworming Mid-upper arm circumference 2 0 5 7
Deworming Test scores 0 0 2 2
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Deworming Weight 3 8 6 17
Deworming Weight-for-age 1 6 5 12
Deworming Weight-for-height 2 7 2 11
Financial literacy Has savings 0 4 1 5
Financial literacy Has taken loan 0 4 0 4
Financial literacy Savings 0 2 3 5
Improved stoves Chest pain 0 0 2 2
Improved stoves Cough incidence 0 0 2 2
Improved stoves Difficulty breathing 0 0 2 2
Improved stoves Excessive nasal secretion 0 1 1 2
Irrigation Consumption 0 1 1 2
Irrigation Total income 0 1 1 2
Microfinance Assets 0 3 1 4
Microfinance Consumption 0 2 0 2
Microfinance Probability of owning business 0 1 1 2
Microfinance Profits 1 3 1 5
Microfinance Savings 0 3 0 3
Microfinance Total income 0 3 2 5
Micro health insurance Enrollment rate 0 1 1 2
Micro health insurance Household health expenditures 0 1 1 2
Micro health insurance Probability of inpatient visit 0 2 0 2
Micro health insurance Probability of outpatient visit 0 2 0 2
Micronutrient supplementation Birthweight 0 4 3 7
Micronutrient supplementation Body mass index 0 1 4 5
Micronutrient supplementation Cough incidence 0 1 1 2
Micronutrient supplementation Cough prevalence 0 2 1 3
Micronutrient supplementation Diarrhea incidence 0 3 10 13
Micronutrient supplementation Diarrhea prevalence 0 5 8 13
Micronutrient supplementation Fever prevalence 0 2 1 3
Micronutrient supplementation Height 3 19 7 29
Micronutrient supplementation Height-for-age 4 21 8 33
Micronutrient supplementation Hemoglobin 6 11 20 37
Micronutrient supplementation Malaria 0 0 3 3
Micronutrient supplementation Mid-upper arm circumference 2 8 7 17
Micronutrient supplementation Mortality 1 10 1 12
Micronutrient supplementation Perinatal death 0 5 1 6
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Micronutrient supplementation Prevalence of anemia 0 0 13 13
Micronutrient supplementation Stillbirth 0 0 4 4
Micronutrient supplementation Stunted 0 0 3 3
Micronutrient supplementation Test scores 1 2 6 9
Micronutrient supplementation Triceps skinfold measurement 1 0 1 2
Micronutrient supplementation Weight 1 17 13 31
Micronutrient supplementation Weight-for-age 1 20 10 31
Micronutrient supplementation Weight-for-height 0 18 8 26
Mobile phone-based reminders Appointment attendance rate 0 0 3 3
Mobile phone-based reminders Treatment adherence 0 2 3 5
Performance pay Test scores 0 2 1 3
Rural electrification Enrollment rate 0 1 2 3
Rural electrification Study time 0 1 2 3
Rural electrification Total income 0 2 0 2
Safe water storage Diarrhea incidence 0 0 2 2
Scholarships Attendance rate 0 1 1 2
Scholarships Enrollment rate 0 2 1 3
Scholarships Test scores 0 2 0 2
School meals Enrollment rate 0 3 0 3
School meals Height-for-age 0 2 0 2
School meals Test scores 0 2 1 3
Water treatment Diarrhea incidence 0 1 5 6
Water treatment Diarrhea prevalence 0 3 7 10
Water treatment Dysentery incidence 0 1 2 3
Women’s empowerment programs Savings 0 1 1 2
Women’s empowerment programs Total income 0 0 2 2
Average 0.4 3.6 3.3 7.3
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Table 11: Heterogeneity Measures for Effect Sizes Within Intervention-Outcomes
Intervention Outcome Units var(Yi) CV(Yi) I
2 N
Rural Electrification Enrollment rate percentage points 0.000 0.14 1.00 3
Financial Literacy Has savings percentage points 0.000 0.52 0.88 4
Conditional Cash Transfers Retention rate percentage points 0.000 1.12 0.98 5
Conditional Cash Transfers Attendance rate percentage points 0.001 0.55 1.00 14
Micronutrients Birthweight kg 0.002 0.99 0.96 7
Conditional Cash Transfers Enrollment rate percentage points 0.002 0.72 1.00 36
Conditional Cash Transfers Labor force participation percentage points 0.002 1.51 0.79 18
Unconditional Cash Transfers Enrollment rate percentage points 0.002 1.00 1.00 13
Conditional Cash Transfers Pregnancy rate percentage points 0.003 1.58 0.96 3
SMS Reminders Appointment attendance rate log risk ratio 0.003 0.32 1.00 3
Financial Literacy Has taken loan percentage points 0.005 2.46 0.99 4
Contract Teachers Test scores standard deviations 0.005 0.40 0.77 3
Conditional Cash Transfers Skilled attendant at delivery percentage points 0.006 0.64 0.85 3
Performance Pay Test scores standard deviations 0.006 0.61 1.00 3
Conditional Cash Transfers Gave birth at healthcare facility percentage points 0.007 1.29 0.92 3
HIV/AIDS Education Used contraceptives percentage points 0.008 2.22 0.14 4
Conditional Cash Transfers Probability unpaid work percentage points 0.009 1.52 0.92 5
Micronutrients Weight-for-height standard deviations 0.010 2.15 0.82 26
Micronutrients Weight-for-age standard deviations 0.010 1.84 0.99 31
Scholarships Enrollment rate percentage points 0.010 0.88 1.00 3
Micronutrients Mid-upper arm circumference cm 0.011 1.73 0.76 17
Micronutrients Diarrhea incidence log risk ratio 0.011 0.89 0.48 7
Micronutrients Height-for-age standard deviations 0.012 2.20 1.00 33
Conditional Cash Transfers Test scores standard deviations 0.013 1.87 1.00 5
School Meals Enrollment rate percentage points 0.016 1.14 0.97 3
Deworming Hemoglobin g/dL 0.018 2.21 0.46 14
Micronutrients Body mass index kg/mˆ2 0.022 0.68 1.00 5
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Micronutrients Test scores standard deviations 0.023 1.93 1.00 9
School Meals Test scores standard deviations 0.023 1.29 0.99 3
Micronutrients Stunted log risk ratio 0.026 2.24 0.05 3
Micronutrients Weight kg 0.046 1.53 1.00 31
Conditional Cash Transfers Height-for-age standard deviations 0.055 22.17 0.04 7
Deworming Weight-for-height standard deviations 0.072 3.13 1.00 11
Deworming Mid-upper arm circumference cm 0.093 3.75 0.99 7
Deworming Height-for-age standard deviations 0.098 1.98 1.00 14
Bed Nets Malaria log risk ratio 0.103 0.70 0.07 10
Deworming Weight-for-age standard deviations 0.107 2.29 1.00 12
Micronutrients Perinatal death log risk ratio 0.118 2.07 0.02 6
Deworming Weight kg 0.153 2.66 1.00 17
Micronutrients Prevalence of anemia log risk ratio 0.170 0.75 0.31 13
Micronutrients Diarrhea prevalence log risk ratio 0.197 1.09 0.01 6
Deworming Height cm 0.217 5.58 0.65 16
Water Treatment Diarrhea prevalence log rate ratio 0.218 1.08 0.70 9
Micronutrients Hemoglobin g/dL 0.222 1.68 1.00 37
Micronutrients Stillbirth log risk ratio 0.236 3.00 0.00 4
Micronutrients Mortality log risk ratio 0.259 15.63 0.01 11
Water Treatment Diarrhea incidence log rate ratio 0.276 0.73 0.05 5
Micronutrients Height cm 0.309 2.88 0.84 29
Water Treatment Dysentery incidence log rate ratio 0.376 0.67 0.00 3
Rural Electrification Study time hours/day 1.382 1.06 0.01 3
Conditional Cash Transfers Unpaid labor hours hours/week 1.933 0.92 0.00 5
Conditional Cash Transfers Labor hours hours/week 4.354 1.05 0.00 7
Microfinance Total income current US$ 512.417 0.96 0.00 5
Microfinance Savings current US$ 5295.826 1.77 0.00 3
Microfinance Profits current US$ 6165.543 5.45 0.00 5
Financial Literacy Savings current US$ 9063.067 5.47 0.00 5
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Microfinance Assets current US$ 14432.350 5.51 0.00 4
Average 622.464 2.35 0.62 10
Median 0.024 1.53 0.84 6
Wherever I2 appears equal to 1.00, this is the result of rounding.
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Table 12: Across-Paper vs. Mean Within-Paper Heterogeneity
Intervention Outcome Across-paper Within-paper Across-paper Within-paper Across-paper Within-paper
var(Yi) var(Yi) CV(Yi) CV(Yi) I
2 I2
Conditional Cash Transfers Attendance rate 0.001 0.001 0.55 0.53 1.00 0.96
Micronutrients Birthweight 0.002 0.002 0.99 0.94 0.96 0.99
Conditional Cash Transfers Enrollment rate 0.002 0.006 0.72 0.88 1.00 0.88
Conditional Cash Transfers Labor force participation 0.002 0.003 1.51 4.30 0.79 0.96
Unconditional Cash Transfers Enrollment rate 0.002 0.003 1.00 1.43 1.00 0.71
HIV/AIDS Education Used contraceptives 0.008 0.394 2.22 6.97 0.14 0.07
Conditional Cash Transfers Probability unpaid work 0.009 0.001 1.52 0.65 0.92 0.86
Micronutrients Weight-for-height 0.010 0.005 2.15 * 0.82 0.61
Micronutrients Weight-for-age 0.010 0.124 1.84 0.71 0.99 0.59
Scholarships Enrollment rate 0.010 0.005 0.88 1.56 1.00 0.70
Micronutrients Diarrhea incidence 0.011 0.064 0.89 1.88 0.48 0.51
Micronutrients Height-for-age 0.012 0.042 2.20 3.75 1.00 0.41
Deworming Hemoglobin 0.018 0.034 2.21 7.39 0.46 0.80
Micronutrients Stunted 0.026 0.080 2.24 40.89 0.05 0.01
Micronutrients Weight 0.046 0.008 1.53 0.10 1.00 0.38
Conditional Cash Transfers Height-for-age 0.055 0.002 22.17 1.21 0.04 0.70
Deworming Weight-for-height 0.072 0.164 3.13 * 1.00 0.97
Deworming Height-for-age 0.098 0.005 1.98 1.84 1.00 0.80
Bed Nets Malaria 0.103 0.209 0.70 0.61 0.07 0.50
Deworming Weight-for-age 0.107 0.004 2.29 1.04 1.00 0.84
Micronutrients Perinatal death 0.118 0.038 2.07 0.22 0.02 0.00
Deworming Weight 0.153 0.116 2.66 1.89 1.00 0.57
Micronutrients Diarrhea prevalence 0.197 0.037 1.09 6.95 0.01 0.03
Deworming Height 0.217 0.145 5.58 0.01 0.65 0.40
Water Treatment Diarrhea prevalence 0.218 0.334 1.08 1.01 0.70 0.08
Micronutrients Hemoglobin 0.222 0.051 1.68 0.56 1.00 1.00
Micronutrients Mortality 0.259 0.640 15.63 1.56 0.01 0.00
Water Treatment Diarrhea incidence 0.276 0.117 0.73 0.56 0.05 0.19
Micronutrients Height 0.309 0.072 2.88 3.38 0.84 0.20
Conditional Cash Transfers Unpaid labor hours 1.933 0.951 0.92 0.85 0.00 0.00
Conditional Cash Transfers Labor hours 4.354 5.424 1.05 3.28 0.00 0.22
Microfinance Total income 512.417 2411.402 0.96 1.23 0.00 0.00
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Within-paper values are based on those papers which report results for different subsets of the data. For closer comparison of the across and
within-paper statistics, the across-paper values are based on the same data set, aggregating the within-paper results to one observation per
intervention-outcome-paper. Each paper needs to have reported 3 results for an intervention-outcome combination for it to be included in
the calculation, in addition to the requirement of there being 3 papers on the intervention-outcome combination. Due to the slightly
different sample, the across-paper statistics diverge slightly from those reported elsewhere in the paper. Occasionally, within-paper measures
of the mean equal or approach zero, making the coefficient of variation undefined or unreasonable; * denotes those coefficients of variation
that were either undefined or greater than 1,000,000. Wherever I2 appears equal to 1.00, this is the result of rounding.
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Table 13: Actual Variance vs. Variance for Prediction Error Thresholds
Intervention Outcome Units Y¯i varpYiq var25 var50
Rural Electrification Enrollment rate percentage points 0.077 0.000 0.001 0.005
Financial Literacy Has savings percentage points 0.024 0.000 0.000 0.001
Conditional Cash Transfers Retention rate percentage points -0.012 0.000 0.000 0.000
Conditional Cash Transfers Attendance rate percentage points 0.069 0.001 0.001 0.004
Micronutrients Birthweight kg 0.042 0.002 0.000 0.002
Conditional Cash Transfers Enrollment rate percentage points 0.061 0.002 0.001 0.003
Conditional Cash Transfers Labor force participation percentage points -0.029 0.002 0.000 0.001
Unconditional Cash Transfers Enrollment rate percentage points 0.050 0.002 0.000 0.002
Conditional Cash Transfers Pregnancy rate percentage points -0.033 0.003 0.000 0.001
SMS Reminders Appointment attendance rate log risk ratio 0.179 0.003 0.005 0.028
Financial Literacy Has taken loan percentage points 0.028 0.005 0.000 0.001
Contract Teachers Test scores standard deviations 0.182 0.005 0.005 0.029
Conditional Cash Transfers Skilled attendant at delivery percentage points 0.123 0.006 0.002 0.013
Performance Pay Test scores standard deviations 0.131 0.006 0.003 0.015
Conditional Cash Transfers Gave birth at healthcare facility percentage points 0.065 0.007 0.001 0.004
HIV/AIDS Education Used contraceptives percentage points 0.041 0.008 0.000 0.001
Conditional Cash Transfers Probability unpaid work percentage points -0.062 0.009 0.001 0.003
Micronutrients Weight-for-height standard deviations 0.045 0.010 0.000 0.002
Micronutrients Weight-for-age standard deviations 0.054 0.010 0.000 0.002
Scholarships Enrollment rate percentage points 0.114 0.010 0.002 0.011
Micronutrients Mid-upper arm circumference cm 0.059 0.011 0.001 0.003
Micronutrients Diarrhea incidence log risk ratio -0.120 0.011 0.002 0.013
Micronutrients Height-for-age standard deviations 0.050 0.012 0.000 0.002
Conditional Cash Transfers Test scores standard deviations 0.062 0.013 0.001 0.003
School Meals Enrollment rate percentage points 0.111 0.016 0.002 0.011
Deworming Hemoglobin g/dL 0.060 0.018 0.001 0.003
Micronutrients Body mass index kg/mˆ2 0.218 0.022 0.007 0.041
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Micronutrients Test scores standard deviations 0.078 0.023 0.001 0.005
School Meals Test scores standard deviations 0.117 0.023 0.002 0.012
Micronutrients Stunted log risk ratio -0.072 0.026 0.001 0.004
Micronutrients Weight kg 0.140 0.046 0.003 0.017
Conditional Cash Transfers Height-for-age standard deviations -0.011 0.055 0.000 0.000
Deworming Weight-for-height standard deviations 0.086 0.072 0.001 0.006
Deworming Mid-upper arm circumference cm 0.081 0.093 0.001 0.006
Deworming Height-for-age standard deviations 0.159 0.098 0.004 0.022
Bed Nets Malaria log risk ratio -0.459 0.103 0.032 0.182
Deworming Weight-for-age standard deviations 0.143 0.107 0.003 0.018
Micronutrients Perinatal death log risk ratio 0.167 0.118 0.004 0.024
Deworming Weight kg 0.147 0.153 0.003 0.019
Micronutrients Prevalence of anemia log risk ratio -0.549 0.170 0.046 0.260
Micronutrients Diarrhea prevalence log risk ratio -0.409 0.197 0.025 0.145
Deworming Height cm 0.083 0.217 0.001 0.006
Water Treatment Diarrhea prevalence log rate ratio -0.433 0.218 0.028 0.162
Micronutrients Hemoglobin g/dL 0.280 0.222 0.012 0.068
Micronutrients Stillbirth log risk ratio 0.162 0.236 0.004 0.023
Micronutrients Mortality log risk ratio -0.033 0.259 0.000 0.001
Water Treatment Diarrhea incidence log rate ratio -0.723 0.276 0.080 0.452
Micronutrients Height cm 0.193 0.309 0.006 0.032
Water Treatment Dysentery incidence log rate ratio -0.916 0.376 0.128 0.726
Rural Electrification Study time hours/day 1.104 1.382 0.185 1.054
Conditional Cash Transfers Unpaid labor hours hours/week -1.513 1.933 0.348 1.981
Conditional Cash Transfers Labor hours hours/week -1.990 4.354 0.602 3.424
Microfinance Total income current US$ 23.537 512.417 84.265 479.166
Microfinance Savings current US$ 41.056 5295.826 256.374 1457.844
Microfinance Profits current US$ -14.414 6165.543 31.601 179.696
Financial Literacy Savings current US$ -17.399 9063.067 46.043 261.820
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Microfinance Assets current US$ 21.811 14432.350 72.360 411.467
var25 represents the variance that would result in a 25% prediction error for draws from a normal distribution centered at the mean Yi
within an intervention-outcome, Y¯i. var50 represents the variance that would result in a 50% prediction error.
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Table 14: Heterogeneity Measures for RCTs
Intervention Outcome Units var(Yi) CV(Yi) I
2 N
Financial Literacy Has savings percentage points 0.000 0.52 0.87 4
Conditional Cash Transfers Attendance rate percentage points 0.001 0.53 1.00 7
Micronutrients Birthweight kg 0.002 0.99 0.96 7
Conditional Cash Transfers Enrollment rate percentage points 0.002 0.63 1.00 20
Conditional Cash Transfers Labor force participation percentage points 0.003 1.95 0.83 7
Unconditional Cash Transfers Enrollment rate percentage points 0.003 0.93 1.00 8
SMS Reminders Appointment attendance rate log risk ratio 0.003 0.32 0.99 3
HIV/AIDS Education Used contraceptives percentage points 0.004 0.85 1.00 3
Financial Literacy Has taken loan percentage points 0.005 2.46 0.99 4
Contract Teachers Test scores standard deviations 0.005 0.40 0.77 3
Performance Pay Test scores standard deviations 0.006 0.61 1.00 3
Micronutrients Weight-for-height standard deviations 0.009 2.40 0.76 25
Micronutrients Weight-for-age standard deviations 0.010 2.07 0.98 29
Micronutrients Diarrhea incidence log risk ratio 0.011 0.89 0.58 7
Conditional Cash Transfers Test scores standard deviations 0.012 1.19 0.33 4
Micronutrients Mid-upper arm circumference cm 0.013 2.15 0.87 14
Micronutrients Height-for-age standard deviations 0.013 2.16 1.00 32
Conditional Cash Transfers Height-for-age standard deviations 0.013 1.44 0.11 3
Deworming Hemoglobin g/dL 0.018 2.21 0.43 14
Micronutrients Test scores standard deviations 0.021 1.45 1.00 8
School Meals Test scores standard deviations 0.023 1.29 1.00 3
Micronutrients Stunted log risk ratio 0.026 2.24 0.05 3
Micronutrients Body mass index kg/mˆ2 0.037 1.10 1.00 3
Micronutrients Weight kg 0.046 1.60 0.99 28
Deworming Weight-for-height standard deviations 0.072 3.13 1.00 11
Deworming Mid-upper arm circumference cm 0.093 3.75 1.00 7
Deworming Height-for-age standard deviations 0.098 1.98 1.00 14
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Bed Nets Malaria log risk ratio 0.103 0.70 0.07 10
Deworming Weight-for-age standard deviations 0.107 2.29 1.00 12
Micronutrients Perinatal death log risk ratio 0.118 2.07 0.02 6
Deworming Weight kg 0.153 2.66 1.00 17
Micronutrients Prevalence of anemia log risk ratio 0.182 0.80 0.29 12
Micronutrients Diarrhea prevalence log risk ratio 0.197 1.09 0.01 6
Deworming Height cm 0.217 5.58 0.59 16
Water Treatment Diarrhea prevalence log rate ratio 0.218 1.08 0.76 9
Micronutrients Hemoglobin g/dL 0.228 1.72 1.00 36
Micronutrients Stillbirth log risk ratio 0.236 3.00 0.00 4
Micronutrients Mortality log risk ratio 0.259 15.63 0.01 11
Water Treatment Diarrhea incidence log rate ratio 0.276 0.73 0.04 5
Micronutrients Height cm 0.312 2.48 0.99 27
Water Treatment Dysentery incidence log rate ratio 0.376 0.67 0.00 3
Conditional Cash Transfers Labor hours hours/week 5.558 1.20 0.00 5
Financial Literacy Savings current US$ 9063.067 5.47 0.00 5
Average 210.980 2.06 0.66 11
Median 0.026 1.45 0.87 7
Wherever I2 appears equal to 1.00, this is the result of rounding.
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Table 15: Heterogeneity Measures for Higher-Quality Studies
Intervention Outcome Units var(Yi) CV(Yi) I
2 N
Financial Literacy Has savings percentage points 0.000 0.52 0.87 4
Micronutrients Birthweight kg 0.001 0.70 1.00 4
Conditional Cash Transfers Attendance rate percentage points 0.002 0.51 1.00 3
Unconditional Cash Transfers Enrollment rate percentage points 0.003 0.93 1.00 8
Conditional Cash Transfers Enrollment rate percentage points 0.003 0.73 1.00 10
HIV/AIDS Education Used contraceptives percentage points 0.004 0.85 1.00 3
Financial Literacy Has taken loan percentage points 0.005 2.46 0.99 4
Contract Teachers Test scores standard deviations 0.005 0.40 0.75 3
Conditional Cash Transfers Test scores standard deviations 0.006 0.58 0.88 3
Conditional Cash Transfers Labor force participation percentage points 0.009 2.93 0.97 3
Micronutrients Weight-for-height standard deviations 0.009 2.30 0.72 24
Micronutrients Weight-for-age standard deviations 0.010 1.85 0.99 28
Micronutrients Diarrhea incidence log risk ratio 0.011 0.89 0.54 7
Micronutrients Mid-upper arm circumference cm 0.013 1.96 0.78 14
Micronutrients Height-for-age standard deviations 0.013 2.05 1.00 29
Deworming Hemoglobin g/dL 0.018 2.21 0.49 14
Micronutrients Test scores standard deviations 0.021 1.45 1.00 8
School Meals Test scores standard deviations 0.023 1.29 1.00 3
Micronutrients Stunted log risk ratio 0.026 2.24 0.05 3
Micronutrients Body mass index kg/mˆ2 0.027 0.83 1.00 4
Micronutrients Weight kg 0.050 1.49 0.99 28
Deworming Weight-for-height standard deviations 0.072 3.13 1.00 11
Deworming Mid-upper arm circumference cm 0.093 3.75 0.99 7
Deworming Height-for-age standard deviations 0.098 1.98 1.00 14
Deworming Weight-for-age standard deviations 0.107 2.29 1.00 12
Bed Nets Malaria log risk ratio 0.135 0.89 0.23 7
Deworming Weight kg 0.161 2.29 1.00 15
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Micronutrients Prevalence of anemia log risk ratio 0.170 0.75 0.28 13
Micronutrients Perinatal death log risk ratio 0.185 3.60 0.02 4
Micronutrients Diarrhea prevalence log risk ratio 0.197 1.09 0.01 6
Micronutrients Hemoglobin g/dL 0.220 1.66 1.00 33
Deworming Height cm 0.228 7.13 0.58 15
Water Treatment Diarrhea prevalence log rate ratio 0.232 1.02 0.77 8
Micronutrients Mortality log risk ratio 0.266 4.01 0.01 9
Water Treatment Diarrhea incidence log rate ratio 0.276 0.73 0.04 5
Micronutrients Height cm 0.324 2.46 0.87 26
Water Treatment Dysentery incidence log rate ratio 0.376 0.67 0.00 3
Conditional Cash Transfers Labor hours hours/week 3.848 0.58 0.00 3
Financial Literacy Savings current US$ 9063.067 5.47 0.00 5
Average 232.572 1.86 0.69 10
Median 0.027 1.49 0.88 7
Wherever I2 appears equal to 1.00, this is the result of rounding.
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